The Biotech Voyager

Jeff Martin
  • 0.0 (0)
  • News Commentary
  • Updated Daily

Biotech's Live show. Dedicated to covering the early stage signals that indicate what's next in the industry.

Episodes

  1. 6d ago

    3D Tissue Printing in SPACE & The Rise of Protein Degraders

    Welcome to The Biotech Voyager. It's the live show that covers where the puck is going in biotech.

    1h 38m

  2. Jun 5

    Cancer Therapeutics Roar, and the Founders of Tolemy Bio (and VelociTx) Join the Show

    Welcome to The Biotech Voyager. It's the show that covers what's next in biotech.

    1h 32m

  3. Jun 3

    OSCO Highlights, GLP1 Gene Therapy, and NK Cell Therapy for Lung Repair

    Welcome to The Biotech Voyager - it's the show that covers what's next in biotech.

    1h 38m

  4. May 29

    Bacterial Tx go Viral, mRNA degraders, & Doudna's CRISPR company puts its first drug into a human

    The Biotech Voyager is the show that covers what's next in biotech.

    1h 42m

  5. May 22

    tRNA Therapies Make a Statement, In vivo CAR-T Rises, and Much More

    The live show that covers what's next in biotech. Join us live!

    1h 43m

  6. May 19

    Molecular Glues Roar, Plus Gene Therapy and Cell Therapy News

    Welcome to The Biotech Voyager. It's the show that covers what's next in biotech.

    1h 26m

  7. May 19

    Special Episode: ASGCT Aftershow

    ASGCT week moved fast. Too fast. So we’re doing a live aftershow on Monday, 11 AM to 12:30 PM EST to break down what happened at ASGCT 2026, the key insights, what surprised us, and what to watch next. Since this is a special one-off event, we will also stream this one live on Linkedin. We'll also have a special guest... so stay tuned. Come hang out with us. Add in your takeaways. See you there!

    1h 22m

  8. May 12

    ASGCT 2026 Pre-Show: What to Watch in Boston

    The Biotech Voyager is going live from 28 Capital's Back Bay offices on Monday to set the stage for ASGCT. We'll be covering the sessions, posters, and conversations worth your time this year, with guest appearances from NanoMosaic and Precede Bio sharing what they're bringing to the meeting. If you're heading to ASGCT or following from afar, tune in for a focused primer before the chaos begins.

    1h 12m

  9. May 8

    Gene Therapy Using Ultrasound | Epigenetic Editors | $83M Series A for Gamma Delta T Cell Engagers

    Huge stories shaping the future of medicine this week. Researchers are using ultrasound to deliver gene therapy, bypassing traditional delivery methods entirely. Epigenetic editors are offering a new way to modify gene expression without cutting DNA. And a company developing gamma delta T cell engagers just closed an $83M Series A, a massive bet on a less explored branch of cancer immunotherapy. Ben and Jeff break down the science behind each story and what it means for the future of biotech. Tune in live Tuesdays and Thursdays at 11AM EST on The Biotech Voyager.

    1h 41m

  10. May 5

    The Cancer Vaccine Getting a Second Chance & The Future of Precision Medicine

    Diaconos Oncology just released new data in pancreatic cancer, one of the deadliest and hardest-to-treat cancers on the planet. But their approach isn't a typical drug. Ben and Jeff break down how dendritic cell vaccines work, why conventional cancer vaccines keep falling short, and what makes this approach different. Plus, RNA exon editing technology that rewrites disease at the RNA level without touching your DNA, and how AI is quietly transforming surgical pathology. New Episodes Monday, Tuesday and Thursday at 11am EST

    1h 9m

  11. Apr 30

    In vivo CAR-T's Impressive Streak, AI in Surgery & Cancer Vaccines, + John Boyce @ 28 Capital

    In vivo CAR-T keeps stacking wins, AI quietly invades the operating room, and cancer vaccines stage their second act... plus, John Boyce from 28 Capital joins the show. The show will break down the in vivo CAR-T streak that's reshaping how the industry thinks about cell therapy economics, dig into where AI is actually showing up in surgical workflows (and where the hype outpaces the data), and unpack why cancer vaccines are suddenly worth a second look after a decade in the wilderness. Then John Boyce from 28 Capital joins to talk early-stage biotech investing, what's catching his attention right now, and where he thinks the smart money is rotating in 2026.

    2h 2m

  12. Apr 29

    The Craziest Immunotherapy We've Ever Seen + CNS Gene Therapy Boom

    Asgard's AT-108 might be the most insane immunotherapy of 2026. .. a first-in-class in vivo cell reprogramming play for cancer. Meanwhile, CNS gene therapy is having a moment: AviadoBio is crossing the blood-brain barrier, Avista's AI-designed capsids are heading to the eye and CSF, and Tenaya just dropped one-year cardiac gene therapy data at ASGCT. Plus: Dr. Nicole Paulk joins live! Her work on CNS-directed AAV gene therapy for glioma puts her right at the center of where this field is heading. Live on the Biotech Voyager. (Both YouTube and Linkedin)

    1h 30m
  • 12 Episodes

About

Biotech's Live show. Dedicated to covering the early stage signals that indicate what's next in the industry.

Information

  • Creator
    Jeff Martin
  • Years Active
    2K
  • Episodes
    12
  • Rating
    Clean